30 Years of Evidence
Take a moment to explore a selection of publications and conference abstracts from around the globe. Find evidence for a wide range of treatment sites including malignant and benign disease, different fractionation schedules and real-time motion synchronization techniques for the CyberKnife® and Radixact®/ TomoTherapy® platforms. We update new papers on a regular basis. See how health professionals are helping to improve patient outcomes.
Featured Content
sarcoma awareness
Neoadjuvant Image-guided Helical Intensity Modulated Radiotherapy of Extremity Sarcomas - A Single Center Experience
sarcoma awareness
Effectiveness and Safety of Tissue Expander for Adjuvant Helical TomoTherapy in Curatively Resected Retroperitoneal Sarcoma
sarcoma awareness
Treatment of Chordomas and Chondrosarcomas With CyberKnife Robotic Hypofractionated Radiosurgery: A Single Institution Experience
Time-resolved Biological Effective Dose Distributions in Stereotactic Radiosurgery for Vestibular Schwannomas: A Comparative Analysis Between Two Dedicated Stereotactic Radiosurgery Systems
Moutsatsos A, Cotrutz C, Stergioula A, Tuleasca C, Pantelis E | Phys Med Biol | 2025
Long-term Outcomes of Ablative Stereotactic Body Radiation Therapy for Inoperable, Non-metastatic Pancreatic Cancer
Cao BY, Zhang LT, Wu CC, Wang J | Radiother Oncol. | 2025
Investigating the Efficacy and Safety of the CyberKnife System for Treating Primary Pancreatic Cancer with Metastases to the Gastrointestinal Tract
Zhang Z, Tian B, Xu H, Huang H, Liang X, Bo C, Bian Y, Wei M, Zhao Z | Cancer Manag Res | 2025
Stereotactic Reirradiation with CyberKnife for Locally Recurrent Prostate Cancer, Long-term Toxicity and Clinical Outcomes from a Monocentric Cohort
Francolini G, Carnevale MG, Di Cataldo V, Loi M, Detti B, Orsatti C, Caprara L, Bertini N, Lorenzetti V, Olmetto E, Bech
Intensity Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: Five-year Outcomes
Carrasquilla M, Sholklapper T, Pepin AN, Hodgins N, Lei S, Rashid A, Danner M, Zwart A, Bolanos G, Ayoob M, Yung T, Aghd
Accuracy of Robotic Radiosurgery in Renal Cell Carcinoma
Hofmann T, Kohlhase N, Eftimova D, Eder MM, Staehler M, Ruge MI, Muacevic A, Fürweger C | Phys Med | 2024
Revisiting Radioresistance: A Systematic Review of Outcomes of Stereotactic Radiosurgery (SRS) in Functional Head and Neck Paragangliomas
Verma O, Mantziaris G, Das L, Sheehan JP, Tripathi M | Neurosurg Rev. | 2025
Hypofractionated Radiosurgery (25 Gy/5 fractions) for Optic Nerve Sheath Meningiomas: Results from an Exploratory Phase 2 Prospective Trial
Fariselli L, Marzoli SB, Morlino S, Pinzi V, Pedone C, De Martin E, Romeo A, Tramacere I, Marchetti M | Int J Radiat Onc
Efficacy and Safety of Donut-Shaped Circumferential Spine CyberKnife Stereotactic Body Radiotherapy for Metastatic Spine Disease
Park DJ, Lee I, Annagiri S, Chou KN, Zamarud A, Akhavan-Sigari A, Hori YS, Persad AR, Abu-Reesh D, Lam FC, Tayag A, Ustr
Computed Tomography Guided Online Adaptive Stereotactic Body Radiation Therapy for Lymph Node Oligometastases: Impact on Dose to Target and Organs at Risk
van Werkhoven LA, Milder MTW, Schillemans W, Hoogeman MS, Nout RA, Nuyttens JJ | Int J Radiat Oncol Biol Phys. | 2025
Pattern of Recurrence After Fractionated Stereotactic Reirradiation in Adult Glioblastoma
Margulies A, Sahki N, Rech F, Vogin G, Blonski M, Peiffert D, Taillandier L, Lesanne G, Demogeot N | Radiat Oncol. | 202
Low-Burden Oligometastatic Disease of the Lung Treated with Robotic Stereotactic Ablative Radiotherapy: A Retrospective Study
Zygogianni A, Koukourakis IM, Liakouli Z, Desse D, Georgakopoulos I, Armpilia C, Lymperopoulou G, Kouloulias V | Biomedi
Risk-adapted Stereotactic Body Radiation Therapy for the Treatment of Large (>3 cm) Primary Lung Cancer with or without Histologic Confirmation: A Propensity Score Matched and Weighted Analysis
Zeng HY, Li YJ, Ji CZ, Wang HH, Yu XR, He Y, Bai H, Zheng BY, Yan YY, Xu JW, Zaorsky NG, Shi JM, Dong Y, Yu XY, Wang JS,
Local Control and Recurrence Patterns after Stereotactic Irradiation Delivered in more than 4 Fractions for Hepatocellular Carcinomas and liver metastases: a retrospective study
Renan A, Bruand M, Jolnerovski M, Diallo A, Demogeot N | Radiat Oncol. | 2025
Time-resolved Biological Effective Dose Distributions in Stereotactic Radiosurgery for Vestibular Schwannomas: A Comparative Analysis Between Two Dedicated Stereotactic Radiosurgery Systems
Moutsatsos A, Cotrutz C, Stergioula A, Tuleasca C, Pantelis E | Phys Med Biol | 2025
Long-term Outcomes of Ablative Stereotactic Body Radiation Therapy for Inoperable, Non-metastatic Pancreatic Cancer
Cao BY, Zhang LT, Wu CC, Wang J | Radiother Oncol. | 2025
Investigating the Efficacy and Safety of the CyberKnife System for Treating Primary Pancreatic Cancer with Metastases to the Gastrointestinal Tract
Zhang Z, Tian B, Xu H, Huang H, Liang X, Bo C, Bian Y, Wei M, Zhao Z | Cancer Manag Res | 2025
Performance Evaluation of SGRT Technology in Conjunction with a Helical Delivery Platform for DIBH in Left-Sided Breast Cancer Treatment
Amit Nirhali et al. | ASTRO | 2025
Obliteration with Preservation: Functional MRI as a Critical Adjunct in Optimizing Radiosurgical Outcomes for Eloquent AVMs
Vangipuram Shankar et al. | ASTRO | 2025
Five-Year Outcomes of Robotic Stereotactic Accelerated Partial Breast Irradiation for Early-Stage Breast Cancer
Tal Sherman et al. | ASTRO | 2025
Evaluation of New SGRT-Based Approach to DIBH for Left-Sided Breast Cancers on a Helical Delivery Platform
Sanjay Hunugundmath et al. | ASTRO | 2025
Interested in conducting research with the CyberKnife® or Radixact® / TomoTherapy® Systems?
If you’re a member of Accuray Exchange (AEx), you can complete a collaboration application form here.
